p16 cdkn2a dna methylation

P16 also known as p16 ink4a cyclin dependent kinase inhibitor 2a cdkn2a multiple tumor suppressor 1 and numerous other synonyms is a protein that slows cell division by slowing the progression of the cell cycle from the g1 phase to the s phase thereby acting as a tumor suppressor it is encoded by the cdkn2a gene a deletion the omission of a part of the dna sequence during replication.

P16 cdkn2a dna methylation. In the case analysis based on p16 methylation the mutation polymorphism of p53 was found to be significantly associated with the risk of esophageal carcinoma. Mgmt gene silencing is a rare event in soft tissue sarcoma. Cdkn2a epigenetic silencing was found in 53 102 191 of samples whereas cdkn2a mutations were observed in 4 of hcc patients indicating that dna methylation is the predominant mechanism for cdkn2a inactivation figure 2b table s4a in hcc. This gene encodes a 190 kd nuclear phosphoprotein that plays a role in maintaining genomic stability and it also acts as a tumor suppressor.

The brca1 gene contains 22 exons spanning about 110 kb of dna. It is ubiquitously expressed in many tissues and cell types. Tumor suppresor genes that contain highly methylated cpg islands in tumor cells affect cell cycle p16 ink4a p15 ink4b rb p14 arf dna repair brca1 hmlh1 mgmt cell adherence cdh1 cdh13 apoptosis dapk tms1 carcinogen metabolism gstp1 hormonal response rarb2 er etc. In the past cancer of the oropharynx throat was associated with the use of alcohol or tobacco or both but the majority of cases are now associated with the hpv virus acquired by having oral contact.

Here we present as far as we are aware the first case of metastatic microcystic adnexal carcinoma with dna sequencing results indicating a mutation in tp53 and chromosomal losses in cyclin dependent kinase inhibitor 2a cdkn2a and cyclin dependent kinase inhibitor 2b cdkn2b. 15 moreover the cyclin dependent kinase inhibitor 2a cdkn2a is a tumor suppressor gene that significantly increases the methylation frequency during esophageal carcinoma. We subjected prototypical cases of the most common soft tissue and bone tumours non mesenchymal tumours that might mimic mesenchymal. Dna methylation of mgmt cdkn2a and mlh1 were more frequent in tumour than in matched normal tissues.

Dna methylation profiling of prototypical sarcomas. Both act as tumor suppressors by regulating the cell cycle. The encoded protein combines with other tumor suppressors dna damage sensors and signal transducers to form a large multi subunit protein complex known as the brca1 associated genome. P16 dna methylation in in patients with b cell non hodgkin lymphoma.